Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Vaccines Summit 2018

About Conference

ConferenceSeries Ltd looks forward to welcome all the participants across the world to attend "29th International Conference on Vaccines and Immunization" during February 19-20, 2018 in Paris, France. The conference highlights the theme “Highights of latest technologies and innovations in Vaccines and Immunization”.

Following the great success of the 19th International Conference on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany, ConferenceSeries Ltd is organizing the 29th International Conference on Vaccines and Immunization, February 19-20, 2018 Paris, France. This will be one of the best in the ConferenceSeries Ltd annual vaccine meeting series with 300 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccine researchers and immunologists around the world are concerned about development and proper applications of Vaccines and immunization; Vaccines and immmunization 2018 to be held in Paris, France from February 19-20, 2018 is a best opportunity to reach the largest assemblage of participants from the Vaccine development community. Explicit presentations where participants can distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines and immunization are hallmarks of this conference.

Target Audience:

  • Researchers & Scientists related to Vaccine R&D
  • Deans and Professors
  • Directors, CEOs, Presidents and Vice Presidents
  • University Faculty
  • Medical Schools/Colleges
  • Nursing Schools/Colleges
  • Associations and Societies related to Vaccine R&D
  • Vaccination Programme Organising Government and Non-government Organisations
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Manufacturing Companies
  • Vaccine Developers and Investigators

 

Sessions/Tracks

ConferenceSeries Ltd is organizing "29th International Conference on Vaccines and Immunization" during February 19-20, 2018 in Paris, France which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Vaccines Summit 2018 features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics.

Vaccines Summit 2018 conference aims to promote and share knowledge on current research & production of vaccines. The conference gathers Immunology specialists, Scientists, Professors and research faculty from academia, Clinical, Veterinary, Medical, CEO’s, Presidents, Policy makers, Professionals from regulatory agencies, Public health professionals, Business delegates of vaccines, Value Chain community of the vaccines with the following profession areas: Innovators, Disruptors, and Influencers, Post doc and PhD students in allied disciplines across the globe under a single roof gather in Phoenix to speak on current research and future strategies for development and production of vaccine.

 

Track 1: Vaccines Against infectious diseases

Live vaccines – also called attenuated vaccines – contain viruses that have been weakened, but not destroyed, in a laboratory. The tension exists because public health regulations aim to protect as many people as possible individual rights and public health stances toward vaccination, various religious standpoints and vaccine objections, and suspicion and mistrust of vaccines among different U.S. and global cultures and communities. Infectious diseases are illnesses caused by the spread of microorganisms (bacteria, viruses, fungi or parasites) or prions to humans from other humans, animals or the environment, including food and water.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


Track 2: Cancer Vaccines

Therapeutic vaccination against tumor antigens is a promising approach to treat cancer. Detailed molecular knowledge of the peptide antigens recognized by tumor-specific T cells and animal experimentation have led to successful clinical studies in patients with Human Papilloma Virus-induced malignancies. Following our successful trials we aim to improve the peptide vaccines with strong adjuvants allowing the eradication of highly aggressive metastatic cancers. Animal studies indicated that combinations with ligands for Toll like receptors and/or agonistic antibodies against CD40 can effectively enhance immunity against tumor antigens. In this project we will label these compounds with near-infrared (NIR) dyes and track their in vivo behavior following administration by different routes and formulations using extremely sensitive in vivo fluorescence imaging systems


29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 


Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 3:  DNA, Protein and Toxoid Vaccines

The measurement of DNA content of cells is one of the earliest and major application in flow cytometry  and still is one that is extensively used today. Large inactivated toxins such as tetanus toxoid, diphtheria toxoid and diphtheria CRM197 are used as carriers in vaccines to develop strong immune responses.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 4: Combination and Conjugate Vaccines

Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections does not increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 5: Travel and Edible vaccines

Vaccines have accomplished near miracles in the fight against infectious disease modified" plants edible vaccines fall under the increasingly unpopular rubric of "genetically. Yellow Fever, Hepatitis (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, and Hepatitis G), Malaria, Typhoid, Polio, Tetanus, Meningitis or Meningococcal Disease, Japanese Encephalitis, Cholera, and Rabies.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands

Track 6: Malaria and TB Vaccines

Malaria causes anemia, which leads to increased health risks and mortality for those who are infected by both diseases. Anemia is a principal concern for pregnant women in developing countries, as it can cause low birth weights, premature births and lower child survival rates. In addition, as many as 50 million school children may be co-infected with malaria and at least one NTD, leaving them more vulnerable to illness and death Individuals with any of the intestinal worm infections have a greater risk of developing active pulmonary tuberculosis. Intestinal worm infections have also been shown to reduce the effectiveness of tuberculosis treatments. Like several NTDs

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 


Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


Track 7: Paediatric Vaccination

Vaccines contain weakened versions of a virus or versions that look like a virus called antigens. This means the antigens cannot produce the signs or symptoms of the disease, but they do stimulate the immune system to create antibodies. These antibodies help protect you if you are exposed to the virus in the future. Vaccines not only help keep your child healthy, they help all children by stamping out serious childhood diseases.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 8: Vaccines for Immune mediated Diseases

Immune Mediated Hemolytic Anemia. Auto -Immune   Hemolytic Anemia AIHA. Appear to be the same disease with different names. The prednisone and Prednisolone are the most commonly prescribed drugs and while they do suppress the body’s immune system from attacking itself. These are valid concerns, as there have been reports in the human literature of recent vaccination being associated with idiopathic thrombocytopenic purpura

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


Track 9: Vaccination for Emerging and Re-emerging diseases

Since the realization that disease can be caused by infection and the establishment of Koch’s postulates, designed to demonstrate that a specific microbe causes a disease, humans have sought to identify and “cure” diseases. However, while we have been successful as a species at developing treatments for numerous microbes, viruses, and even parasites, pure cures that prevent future reinfection have remained elusive. Indeed, the only human disease that has been eradicated in the modern era (smallpox) was eliminated through the successful development and application of preventative vaccines, not the implementation of any treatment strategy. Furthermore, the two next most likely candidates for eradication, dracunculiasis (guinea worm disease) and poliomyelitis (polio), are approaching this status through the use of preventative measures, via water filtration and vaccination, respectively. In fact, despite the recent pushback from a scientifically unfounded anti- vaxxers movement, the use of a standardized vaccination regimen has led to clear reductions in disease incidence of numerous childhood ailments in the Americas, including measles, mumps, rubella, and many others. Thus, although the development of antibiotics and other medical interventions have dramatically improved human health, vaccines remain the gold standard of preventative treatment for the potential of disease elimination.
 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 


Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 10: Vaccine production and delivery technologies

Vaccine adjuvants - is an ingredient of a vaccine that helps to create a stronger immunization in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines prepared from weakened or dead microbes will contain naturally occurring adjuvants and it will help the body to produce a strong protective immunization.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


Track 11: Vaccine Safety and Efficacy

Vaccine efficacy refers to the ability of a vaccine to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.


29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

Track 12: Vaccines Industry & Manufacturing

Vaccines, in general, help protect people from harmful infections before they come in contact with the disease.  Vaccines may also help alleviate the symptoms of the infection caused by the virus. Vaccine process technology; fermentation; cell

Culture purification; formulation; manufacturing. Allaying the threat of preventable deaths, vaccines are one of the most important arsenal for public health globally.  vaccine industry has time and again, broken affordability barriers, addressed technology challenges and has earned India the recognition of having the largest global capacity for WHO prequalified vaccine manufacturing. The real laurel in the export success rests in the markets served and the consequent public health impact.

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

Track 13: Geriatric Immunization

Immunizations can protect your child against serious diseases that can make your child very sick. These diseases can even cause brain damage or death. Immunizations also protect the community. If children are not immunized, they can be a health threat to babies too young or sick to get all their shots.

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


Track 14: Vaccines for unconventional disease

It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional indications. These vaccines have been in most cases developed so far as treatment vaccines. This is in opposite to infectious diseases vaccines used as prophylactic vaccines. Despite promising late stage candidates, with some very recent failures, there is still no antibody-inducing vaccine approved targeting other than microorganism antigens (i. e targeting self-antigens , addiction molecules antigens and others. It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional


29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 


Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

15. Animal and Plant Derived Vaccines

Plants produce appropriately folded, Post–Translationally processed proteins that, as antigens, elicit efficacious immune responses in preclinical animal models and antigen-specific responses in humans. Plant-produced vaccine candidates have been produced using transgenic technologies and the utilization of plant viruses for the transient protein expression. Source: An updated graph from the “Active immunization for unconventional indications” Report on www.martinalutter.comIt is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional indications. These vaccines have been in most cases developed so far as treatment vaccines. This is in opposite to infectious diseases vaccines used as prophylactic vaccines. Despite promising late stage candidates, with some very recent failures, there is still no antibody-inducing vaccine approved targeting other than microorganism antigens (i. e targeting self-antigens , addiction molecules antigens and others. It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional indication

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 


Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands., Netherlands.

 

16. Vaccines for Pregnant women and Neonates

Immunization during pregnancy has the potential to protect the mother and the infant against vaccine preventable diseases. New born infants are at high-risk for significant illness and death from certain infectious diseases because their immune system has not fully developed. One aim of vaccinating pregnant women is to increase the amount of maternal antibody (proteins that fight disease) transferred to infants, potentially protecting them from infectious disease.

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

17. Animal Models and Clinical Trials

There are several different kinds of clinical trials. Trials are designed to test cancer prevention, screening, treatment and methods to improve the quality of life for cancer patients. Clinical trials are performed to evaluate the safety and efficacy of potential cancer treatments enrollment in a treatment trial does not mean that the patient will only be taking an experimental treatment. Often new drugs or treatments are combined with current treatments/drugs to see if there is an added benefit to the patient. Animal sufficiently like humans in its anatomy, physiology, or response in order to obtain results that can

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


18. Cellular Immunology and Latest Innovations

The field concerning the interactions among cells and molecules of the immune system and howsuch interactions contribute to the recognition and elimination of pathogens.

Human and vertebrates in general. Possess a range of nonspecific mechanical and biochemical defences against routinely
 

The skin, for example, is aneffective physical barrier to infection. Basic chemical defenses are also present in blood, saliva, and tears, and on mucous membranes. In contrast, the adaptive immune response is more complex and specific. During the first days of infection, specialized cells process and present foreign antigens to the adaptive immune system once a specific antigen has been recognized, the adaptive immune system uses a complex network of cells and molecules to specifically attack pathogens expressing this antigen. The cells activated during this process will expand and give rise to “memory” cells that can quickly recognize the same antigens if the organism is infected by the pathogen again.


29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

19. Clinical Immunology & Cancer Immunotherapy

The nature of the immune system and its response to malignancies .To explore auto- and auto-immune responses to cancer with the goal of enabling the discovery and development of more effective anti-tumour immune therapy. These goals will be achieved by fostering collaborative research, advancing the latest technologies to probe immunological mechanisms, and by enhancing the infrastructure for clinical translation. Research by program members has resulted in exciting new developments in both understanding immune function and developing novel therapies. Advances include the development and application of Cy TOF and high-throughput sequencing for evaluating cellular function and responses and the translation of important concepts to the clinic in promising early phase clinical trials

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

20. Molecular and Structural Immunology

 

In each cell, countless molecular machines work ceaselessly to keep vital processes going. These include protein factories (ribosomes) and “shredders” (proteasomes), which dispose of defective or no longer needed proteins. They consist of proteins which have joined forces in large complexes. However, before the scientists can gain insight into their function, they must identify their structure. With established research methods, this has often not been possible so far.

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland;  Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

21. Antibodies Engineering and Therapeutics

 

Product heterogeneity is common in monoclonal antibodies and other recombinant biological products and is typically introduced either upstream during expression or downstream during manufacturing These variants are typically aggregates, deamidation products, glycosylation variants, oxidized amino acid side chains, as well as amino and carboxyl terminal amino acid additions. These seemingly minute structural changes can affect preclinical stability and process optimization as well as therapeutic product potency, bioavailability and immunogenicity. The generally accepted purification method of process streams for monoclonal antibodies includes capture of the product target with protein A, elution, acidification to inactivate potential mammalian viruses, followed by ion chromatography, first with anion beads and then with cation beads.

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 


Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.


22. Hepatitis, HIV and STD Vaccines

Integration is based on the understanding that a risk behaviour, such as injecting drugs or having unprotected sex, can put an individual at risk for multiple infections, and that the prevention and treatment of these multiple infections can be addressed in a single intervention or service visit.1 Ideally, integrated services should give clients, regardless of the initial reason for seeking care, seamless access to comprehensive services for HIV.

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

 

23. Bacterial and Viral Vaccines

Integration is based on the understanding that a risk behaviour, such as injecting drugs or having unprotected sex, can put an individual at risk for multiple infections, and that the prevention and treatment of these multiple infections can be addressed in a single intervention or service visit. Ideally, integrated services should give clients, regardless of the initial reason for seeking care, seamless access to comprehensive services for HIV.

 

29th international conference on Vaccines and immunization February 19-20, 2018 Paris, France; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Past Conference Report

Vaccines Summit 2017

Past Reports  Proceedings  Gallery  

Supported By

Journal of Vaccines & Vaccination Journal of Clinical & Cellular Immunology Immunome Research

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by